Vessel Due F 50 capsules — Made in Italy — Free Delivery

Product description

Soft capsules Vessel Due F are indicated for:

• angiopathy with an increased risk of thrombus formation, including after myocardial infarction;
• disorders of cerebral circulation, including the acute period of ischemic stroke and the period of early recovery; discirculatory encephalopathy due to atherosclerosis, diabetes mellitus, hypertension; vascular dementia
• occlusive lesions of peripheral arteries of both atherosclerotic and diabetic genesis;
• phlebopathy, deep vein thrombosis;
• microangiopathy (nephropathy, retinopathy, neuropathy) and macroangiopathy in diabetes mellitus (diabetic foot syndrome, encephalopathy, cardiopathy);
• thrombotic conditions, antiphospholipid syndrome (prescribed simultaneously with acetylsalicylic acid).

Compound

Active substance: sulodexide;

1 capsule contains 250 LO (lipoprotein lipase units) sulodexide;

Excipients: sodium lauryl sarcosinate, colloidal silicon dioxide, triacetin, gelatin, glycerin, sodium methyl parahydroxybenzoate (E 215), sodium propyl parahydroxybenzoate (E 217), titanium dioxide (E 171), iron oxide red (E 172).

Contraindications

hypersensitivity to the components of the preparation;

hemorrhagic diathesis and diseases accompanied by decreased blood coagulability;

pregnancy in the first trimester.

Mode of application

1 capsule 2 times a day inside between meals for 30-40 days. The maximum single dose is 4 capsules, the daily dose is 8 capsules. The full course of treatment should be repeated at least 2 times a year. In case of an exacerbation of the disease or in severe cases, treatment should be started with parenteral administration of Wessel Douai F, and then continue with capsules for 20-40 days.

Application features

Pregnant

Since there is no experience of using the preparation  in the first trimester of pregnancy, prescribing the preparation to women during this period should be avoided, unless, in the doctor's opinion, the expected benefit of treatment for the mother outweighs the possible risk to the fetus.

Children

From 12 years old.

Drivers

Does not affect.

Overdose

An overdose of the preparation can lead to the development of hemorrhagic symptoms such as hemorrhagic diathesis or bleeding. In case of bleeding, a 1% solution of protamine sulfate should be administered. In general, in case of an overdose, the use of the preparation  should be discontinued and appropriate symptomatic therapy should be initiated.

Side effects

• nausea, vomiting, epigastric pain;
• skin rash (allergic reaction).

Interaction

Since sulodexide is a heparin-like molecule, when used simultaneously, it can increase the anticoagulant effect of heparin and oral anticoagulants. No other clinically significant preparation interactions have been identified.

Storage conditions

Store at a temperature not exceeding 30 ° C.

Keep out of the reach of children.

The shelf life is 5 years.